BMS Archive

Plant · Scientific monograph

Urtica dioica

Stinging Nettle

For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.

Research areas: Inflammatory Pathways, Prostate & Urological Research, Oxidative Stress Research

Research overview

Historical use

Urtica dioica (stinging nettle) has been used medicinally across Europe, North America, and Asia for at least 2,000 years. Hippocrates described over 60 remedies using nettle. Traditional applications included the leaf for arthritis (urticulation — deliberate stinging of affected joints), anaemia, allergic rhinitis, and as a nutritional tonic rich in iron and vitamins. The root was used separately from the leaf in European herbal traditions for urinary complaints and prostate symptoms. Both preparations appear in the European Pharmacopoeia and are approved by the European Medicines Agency (EMA) for their respective indications.

Modern research context

Urtica dioica has two distinct pharmacological profiles depending on the plant part used. The root (Urticae radix) is the most clinically studied preparation for lower urinary tract symptoms in BPH: a double-blind RCT (n=558, 6 months) found nettle root extract 459 mg/day significantly reduced IPSS score and improved peak urinary flow versus placebo [2]. Root phytosterols inhibit SHBG binding and 5α-reductase, modulating intraprostatic androgen activity [5]. The leaf (Urticae folium) has demonstrated anti-inflammatory efficacy: a randomised pilot RCT (n=27) found topical urticulation (stinging with fresh leaves) comparable to diclofenac gel for knee osteoarthritis pain [4]. A lyophilised extract of leaf significantly reduced pro-inflammatory cytokine production (IL-1β, TNF-α) and inhibited NF-κB activation in human monocytes in vitro [3]. For allergic rhinitis, leaf extract exhibits histamine-releasing (paradoxical) and mast cell-stabilising activity in parallel, with one RCT showing symptom relief superior to placebo [1].

Adverse effects

Leaf preparations: fresh plant contact causes transient urticaria, erythema, and pruritus from histamine, serotonin, and acetylcholine in stinging trichomes. Oral preparations are generally well-tolerated; occasional GI discomfort, diuresis, and mild allergic reactions. Root preparations: well-tolerated in clinical trials; occasional GI upset, sweating, and allergic skin reactions reported [1, 2].

Contraindications

Diuretics — additive diuretic effect and electrolyte depletion risk; monitor electrolytes. Antihypertensives — additive hypotensive effect; monitor BP. Warfarin and anticoagulants — high vitamin K content in leaf preparations may antagonise anticoagulant therapy; standardise dietary intake or avoid high-dose leaf extracts [1, 3]. Antidiabetic drugs — additive glucose-lowering effect in animal models; monitor blood glucose. Lithium — diuretic-mediated lithium retention is a theoretical concern.

Clinical and phytochemical data

Used part

Root (Urticae radix) for BPH/urological use; leaf (Urticae folium) for inflammatory and allergic applications

Primary active compounds

  • Root: β-sitosterol, stigmasterol, campesterol (phytosterols — primary BPH-active fraction)

  • Root: polysaccharides (UDA — Urtica dioica agglutinin, a lectin with immunomodulatory activity)

  • Root: hydroxycoumarins (scopoletin), steryl glycosides

  • Leaf: flavonoids — quercetin, kaempferol, isorhamnetin, rutin

  • Leaf: caffeic acid derivatives — chlorogenic acid, caffeoylmalic acid

  • Leaf: minerals — iron, calcium, silica, potassium (nutritional significance)

  • Leaf: carotenoids, vitamins C and K

Mechanism of action

BPH / Prostate (root): β-Sitosterol and related phytosterols competitively inhibit sex hormone-binding globulin (SHBG) binding to its receptor, reducing prostatic uptake of dihydrotestosterone (DHT). UDA lectins modulate EGF receptor signalling, inhibiting prostate epithelial cell proliferation. 5α-Reductase inhibition partially reduces intraprostatic DHT levels [5]. Anti-inflammatory (leaf): Flavonoids and hydroxycinnamic acids inhibit COX-1/2, 5-LOX, and NF-κB activation, reducing prostaglandin E₂ and leukotriene B₄ production. Caffeic acid malic acid ester inhibits pro-inflammatory cytokines (IL-1β, TNF-α, IL-6) in human macrophages [3].

Pharmacokinetics

Absorption

No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Phytosterols from root extracts are absorbed via lymphatic route; absorption is modest (~5–10%) and enhanced by co-ingestion of dietary fat. Flavonoids from leaf are absorbed in the small intestine with variable bioavailability depending on glycosylation state.

Distribution

No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Phytosterols incorporate into cell membranes and distribute to the liver, prostate, and intestinal mucosa. Quercetin and kaempferol distribute widely; plasma protein binding >90% for flavonoid aglycones.

Metabolism

No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Flavonoids undergo colonic microbial deglycosylation, hepatic phase II glucuronidation, sulfation, and O-methylation. Phytosterols minimally metabolised; not converted to bile acids in humans.

Excretion

No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Phytosterols primarily excreted via bile into faeces. Flavonoid conjugates excreted renally. High urinary flavonoid excretion reflects the pronounced diuretic activity of nettle leaf preparations.

Safety and interactions

Drug interactions

Warfarin — high vitamin K content in leaf can antagonise anticoagulation; monitor INR closely or standardise intake. Diuretics — additive electrolyte-depleting effect; monitor serum potassium. Antihypertensives — additive hypotensive effect. Lithium — diuresis may reduce renal lithium clearance, increasing lithium levels [1, 3].

Toxicity

No significant toxicity in clinical trials at standard doses. Root extract 459 mg/day showed excellent tolerability over 6 months in the largest RCT (n=558) [2]. Contact dermatitis from fresh plant handling is common but self-limiting. No known carcinogenicity or genotoxicity. No hepatotoxicity signal.

Special precautions

Pregnancy

Avoid medicinal-dose preparations. Traditional use as a uterine stimulant; potential abortifacient risk at high doses.

Lactation

Dietary quantities likely safe. High-dose extracts not recommended due to absence of safety data.

Hepatic impairment

No specific data. No known hepatotoxicity at standard doses.

Renal impairment

Use with caution in severe renal impairment — diuretic effect may be exaggerated; monitor electrolytes.

Sources and references

  1. [1] - Chrubasik JE, Roufogalis BD, Wagner H, Chrubasik SA., "A comprehensive review on the stinging nettle effect and efficacy profiles.", Phytomedicine, 2007, PMID: 17302914
  2. [2] - Safarinejad MR., "Urtica dioica for treatment of benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled, crossover study.", J Herb Pharmacother, 2005, PMID: 15901814
  3. [3] - Johnson TA, Sohn J, Inman WD, Bjeldanes LF, Rayburn K., "Lipophilic stinging nettle extracts possess potent anti-inflammatory activity.", J Ethnopharmacol, 2013, PMID: 23350426
  4. [4] - Randall C, Meethan K, Randall H, Dobbs F., "Nettle sting of Urtica dioica for joint pain — an exploratory study of this complementary therapy.", Complement Ther Med, 1999, PMID: 10807448
  5. [5] - Hirano T, Homma M, Oka K., "Effects of stinging nettle root extracts and their steroidal components on the Na+,K(+)-ATPase of the benign prostatic hyperplasia.", Planta Med, 1994, PMID: 7997468

Additional source links

Continue browsing